208 related articles for article (PubMed ID: 17854662)
1. HMGA2 expression in a canine model of prostate cancer.
Winkler S; Murua Escobar H; Meyer B; Simon D; Eberle N; Baumgartner W; Loeschke S; Nolte I; Bullerdiek J
Cancer Genet Cytogenet; 2007 Sep; 177(2):98-102. PubMed ID: 17854662
[TBL] [Abstract][Full Text] [Related]
2. HMGA2 overexpression in non-small cell lung cancer.
Meyer B; Loeschke S; Schultze A; Weigel T; Sandkamp M; Goldmann T; Vollmer E; Bullerdiek J
Mol Carcinog; 2007 Jul; 46(7):503-11. PubMed ID: 17477356
[TBL] [Abstract][Full Text] [Related]
3. Prostate-specific antigen mRNA and protein levels in laser microdissected cells of human prostate measured by real-time reverse transcriptase-quantitative polymerase chain reaction and immuno-quantitative polymerase chain reaction.
Pinzani P; Lind K; Malentacchi F; Nesi G; Salvianti F; Villari D; Kubista M; Pazzagli M; Orlando C
Hum Pathol; 2008 Oct; 39(10):1474-82. PubMed ID: 18619642
[TBL] [Abstract][Full Text] [Related]
4. HMGA2 is associated with invasiveness but not a suitable marker for the detection of circulating tumor cells in breast cancer.
Fabjani G; Tong D; Wolf A; Roka S; Leodolter S; Hoecker P; Fischer MB; Jakesz R; Zeillinger R
Oncol Rep; 2005 Sep; 14(3):737-41. PubMed ID: 16077985
[TBL] [Abstract][Full Text] [Related]
5. HMGA2 mRNA expression correlates with the malignant phenotype in human thyroid neoplasias.
Chiappetta G; Ferraro A; Vuttariello E; Monaco M; Galdiero F; De Simone V; Califano D; Pallante P; Botti G; Pezzullo L; Pierantoni GM; Santoro M; Fusco A
Eur J Cancer; 2008 May; 44(7):1015-21. PubMed ID: 18375116
[TBL] [Abstract][Full Text] [Related]
6. Detection of high-mobility group proteins A1 and A2 represents a valid diagnostic marker in post-pubertal testicular germ cell tumours.
Franco R; Esposito F; Fedele M; Liguori G; Pierantoni GM; Botti G; Tramontano D; Fusco A; Chieffi P
J Pathol; 2008 Jan; 214(1):58-64. PubMed ID: 17935122
[TBL] [Abstract][Full Text] [Related]
7. Prostate stem cell antigen mRNA expression in preoperatively negative biopsy specimens predicts subsequent cancer after transurethral resection of the prostate for benign prostatic hyperplasia.
Zhao Z; Liu J; Li S; Shen W
Prostate; 2009 Sep; 69(12):1292-302. PubMed ID: 19462463
[TBL] [Abstract][Full Text] [Related]
8. Thrombin receptor expression is upregulated in prostate cancer.
Kaushal V; Kohli M; Dennis RA; Siegel ER; Chiles WW; Mukunyadzi P
Prostate; 2006 Feb; 66(3):273-82. PubMed ID: 16245281
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of HMGA2 in thyroid carcinomas: a novel molecular marker to distinguish between benign and malignant follicular neoplasias.
Belge G; Meyer A; Klemke M; Burchardt K; Stern C; Wosniok W; Loeschke S; Bullerdiek J
Genes Chromosomes Cancer; 2008 Jan; 47(1):56-63. PubMed ID: 17943974
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of high mobility group A2 in human gastric cancer and its relationship to let-7 microRNA family.
Motoyama K; Inoue H; Nakamura Y; Uetake H; Sugihara K; Mori M
Clin Cancer Res; 2008 Apr; 14(8):2334-40. PubMed ID: 18413822
[TBL] [Abstract][Full Text] [Related]
11. IgG gene expression and its possible significance in prostate cancers.
Liu Y; Chen Z; Niu N; Chang Q; Deng R; Korteweg C; Gu J
Prostate; 2012 May; 72(6):690-701. PubMed ID: 22430367
[TBL] [Abstract][Full Text] [Related]
12. Comparative gene and protein expression in primary cultures of epithelial cells from benign prostatic hyperplasia and prostate cancer.
Rose A; Xu Y; Chen Z; Fan Z; Stamey TA; McNeal JE; Caldwell M; Peehl DM
Cancer Lett; 2005 Sep; 227(2):213-22. PubMed ID: 16112424
[TBL] [Abstract][Full Text] [Related]
13. Expression analysis and clinical utility of L-Dopa decarboxylase (DDC) in prostate cancer.
Avgeris M; Koutalellis G; Fragoulis EG; Scorilas A
Clin Biochem; 2008 Oct; 41(14-15):1140-9. PubMed ID: 18586020
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of PIM-1 is a potential biomarker in prostate carcinoma.
Xu Y; Zhang T; Tang H; Zhang S; Liu M; Ren D; Niu Y
J Surg Oncol; 2005 Dec; 92(4):326-30. PubMed ID: 16299799
[TBL] [Abstract][Full Text] [Related]
15. Gene expression profile of mouse prostate tumors reveals dysregulations in major biological processes and identifies potential murine targets for preclinical development of human prostate cancer therapy.
Haram KM; Peltier HJ; Lu B; Bhasin M; Otu HH; Choy B; Regan M; Libermann TA; Latham GJ; Sanda MG; Arredouani MS
Prostate; 2008 Oct; 68(14):1517-30. PubMed ID: 18668517
[TBL] [Abstract][Full Text] [Related]
16. The expression of pluripotency marker Oct 3/4 in prostate cancer and benign prostate hyperplasia.
Monsef N; Soller M; Isaksson M; Abrahamsson PA; Panagopoulos I
Prostate; 2009 Jun; 69(9):909-16. PubMed ID: 19274762
[TBL] [Abstract][Full Text] [Related]
17. Canine prostate carcinomas express markers of urothelial and prostatic differentiation.
LeRoy BE; Nadella MV; Toribio RE; Leav I; Rosol TJ
Vet Pathol; 2004 Mar; 41(2):131-40. PubMed ID: 15017026
[TBL] [Abstract][Full Text] [Related]
18. Higher expression of the androgen-regulated gene PSA/HK3 mRNA in prostate cancer tissues predicts biochemical recurrence-free survival.
Sterbis JR; Gao C; Furusato B; Chen Y; Shaheduzzaman S; Ravindranath L; Osborn DJ; Rosner IL; Dobi A; McLeod DG; Sesterhenn IA; Srivastava S; Cullen J; Petrovics G
Clin Cancer Res; 2008 Feb; 14(3):758-63. PubMed ID: 18245536
[TBL] [Abstract][Full Text] [Related]
19. [Quantitative detection of DD3 mRNA in prostate cancer tissues by real-time fluorescent quantitative reverse transcription polymerase chain reaction].
Tao ZH; Mao XL; Wang CH; Chen XD; Yu KY; Weng ZL; Hu YP; Zhang XH; Xie H; Wang OC; Song QT; Li CD; Chen ZG
Zhonghua Nan Ke Xue; 2007 Feb; 13(2):130-3. PubMed ID: 17345768
[TBL] [Abstract][Full Text] [Related]
20. Loss of Nkx3.1 expression in the transgenic adenocarcinoma of mouse prostate model.
Bethel CR; Bieberich CJ
Prostate; 2007 Dec; 67(16):1740-50. PubMed ID: 17929276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]